interestingly it mentions nasal and nasophyarangiel swaps (excuse spelling) but no blood sample. maybe thats what they were having issues with and have just decided to do without as part of the test platform... maybe a decision to allow them to get to market faster...
- Forums
- ASX - By Stock
- GOOD NEWS
interestingly it mentions nasal and nasophyarangiel swaps...
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SE1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online